Evidence map›Paper›PMID 29487760›Full record

ArticleWestern Pacific surveillance and response journal : WPSAR

Trends in adult chlamydia and gonorrhoea prevalence, incidence and urethral discharge case reporting in Mongolia from 1995 to 2016 - estimates using the Spectrum-STI model.

Jugderjav Badrakh, Setsen Zayasaikhan, Davaalkham Jagdagsuren, Erdenetungalag Enkhbat, Narantuya Jadambaa, Sergelen Munkhbaatar, Melanie Taylor, Jane Rowley, Guy Mahiané, Eline Korenromp

Open access · diamondAbstract read
In one paragraph

Article in Western Pacific surveillance and response journal : WPSAR. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Prevalence and incidence estimates for syphilis, chlamydia, gonorrhea, and congenital syphilis in Colombia, 1995-2016.Revista panamericana de salud publica = Pan American journal of public health · 2018
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Jugderjav BadrakhMongolia National Center for Communicable Diseases (NCCD), AIDS/STI Surveillance and Research Department.
Setsen ZayasaikhanMongolia National Center for Communicable Diseases (NCCD), AIDS/STI Surveillance and Research Department.
Davaalkham JagdagsurenMongolia National Center for Communicable Diseases (NCCD), AIDS/STI Surveillance and Research Department.
Erdenetungalag EnkhbatMongolia National Center for Communicable Diseases (NCCD), AIDS/STI Surveillance and Research Department.
Narantuya JadambaaWorld Health Organization Country Office Mongolia.
Sergelen MunkhbaatarMongolia Global Fund-supported project on AIDS and TB.
Melanie TaylorWorld Health Organization, Dept. of Reproductive Health and Research, Geneva, Switzerland.
Jane RowleyLondon, United Kingdom.
Guy MahianéAvenir Health, Glastonbury, CT, USA.
Eline KorenrompAvenir Health, Geneva, Switzerland.
Avenir Health · USWorld Health Organization · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

objectiveTo estimate Mongolia's prevalence and incidence trends of gonorrhoea and chlamydia in women and men 15-49 years old to inform control of STIs and HIV, a national health sector priority.

methodsWe applied the Spectrum-STI estimation model, fitting data from two national population surveys (2001 and 2008) and from routine gonorrhoea screening of pregnant women in antenatal care (1997 to 2016) adjusted for diagnostic test performance, male/female differences and missing high-risk populations. Prevalence and incidence estimates were then used to assess completeness of national case reporting.

resultsGonorrhoea prevalence was estimated at 3.3% (95% confidence interval, 1.6-3.9%) in women and 2.9% (1.6-4.1%) in men in 2016; chlamydia prevalence levels were 19.5% (17.3-21.9%) and 15.6% (10.0-21.2%), respectively. Corresponding new incident cases in women and men in 2016 totalled 60 334 (36 147 to 121 933) and 76 893 (35 639 to 254 913) for gonorrhoea and 131 306 (84 232 to 254 316) and 148 162 (71 885 to 462 588) for chlamydia. Gonorrhoea and chlamydia prevalence declined by an estimated 33% and 11%, respectively from 2001 to 2016.Comparing numbers of symptomatic and treated cases estimated by Spectrum with gonorrhoea case reports suggests that 15% of symptomatic treated gonorrhoea cases were reported in 2016; only a minority of chlamydia episodes were reported as male urethral discharge cases. DISCUSSION: Gonorrhoea and chlamydia prevalence are estimated to have declined in Mongolia during the early 2000s, possibly associated with syndromic management in primary care facilities and improving treatment coverage since 2001 and scale up of HIV/STI prevention interventions since 2003. However, prevalence remains high with most gonorrhoea and chlamydia cases not treated or recorded in the public health system.

Indexed as

AdolescentAdultChlamydia InfectionsFemaleGonorrheaHumansIncidenceMaleMiddle AgedModels, StatisticalMongoliaPregnancyPrevalenceUrethraYoung Adult

Identifiers

PMID29487760
PMCPMC5803554
OpenAlexW2789753613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.